Cannabis and Panic Disorder
What the evidence actually says about using cannabis, CBD, or THC for panic attacks and panic disorder.
Here's the uncomfortable truth: cannabis is one of the most common drug-induced causes of acute panic attacks, and there are no quality trials showing it treats panic disorder. CBD has some interesting early data for general anxiety and public-speaking fear, but panic disorder specifically hasn't been studied well. If you have panic disorder and cannabis sometimes helps you relax, that's not nothing — but the same drug triggers full-blown panic attacks in a meaningful minority of users, including regular ones. Tread carefully.
Not medical advice
This article is not medical advice. Panic disorder is a treatable psychiatric condition. If you are having panic attacks, talk to a licensed clinician — ideally a psychiatrist or a therapist trained in cognitive behavioral therapy (CBT). Nothing here replaces individualized care, and decisions about cannabis interact with your other medications, your psychiatric history, and local law.
Plain-language summary
Panic disorder is a condition defined by recurrent, unexpected panic attacks plus persistent worry about having more of them [1]. It is not the same as occasional anxiety or stress.
Cannabis has a complicated relationship with panic:
- It causes panic attacks. Acute anxiety and panic are among the most commonly reported adverse effects of THC, especially at higher doses, in less experienced users, or in people prone to anxiety [2][3].
- People with panic disorder use it anyway. Self-medication is common, and some users report short-term relief [4].
- Long-term cannabis use is associated with higher rates of anxiety disorders, though causation is debated [5].
- CBD (cannabidiol) is different from THC and has some early evidence for anxiety reduction, but panic disorder specifically has barely been studied [6][7].
There are no large randomized trials of cannabis, THC, or CBD as a treatment for panic disorder.
What probably works (strong evidence)
For panic disorder itself, none of it is cannabis-based. The treatments with strong evidence are:
- SSRIs and SNRIs (e.g., sertraline, paroxetine, venlafaxine) — first-line pharmacotherapy [8].
- Cognitive behavioral therapy (CBT), particularly with interoceptive exposure — equally effective to medication, with more durable results [8][9].
- Benzodiazepines for short-term or rescue use, with well-known dependence risks [8].
If you take only one thing from this article: CBT for panic disorder is one of the better-supported treatments in all of psychiatry. Cannabis is not in that category. Strong evidence
What might work (weak or indirect evidence)
CBD for anxiety symptoms (not panic disorder specifically). A small but real body of human research suggests CBD reduces anxiety in specific contexts:
- A 2011 trial in social anxiety disorder found 600 mg oral CBD reduced anxiety during a simulated public speaking test [6]. Weak / limited
- A 2019 open-label case series in psychiatric outpatients reported reduced anxiety scores over three months [7]. Weak / limited
- Reviews note generally promising signals for generalized anxiety, social anxiety, and PTSD-related anxiety, with the strong caveat that most studies are small, short, and not specific to panic disorder [10].
Whether any of this transfers to panic disorder — a distinct diagnosis with a different neurobiology emphasizing interoceptive misinterpretation and the locus coeruleus — is unknown. No data
Low-THC, high-CBD products are sometimes reported by patients to cause less acute anxiety than high-THC flower or concentrates. This is plausible mechanistically but rests largely on user reports, not controlled trials. Anecdote
What doesn't work, or where evidence is weak
- High-THC cannabis as a panic disorder treatment. No controlled evidence supports this, and acute panic is a well-documented adverse effect of THC [2][3]. [evidence:none for benefit; strong for harm]
- "Indica calms panic, sativa worsens it." The indica/sativa distinction does not reliably predict effects; chemovar (cannabinoid + terpene profile) matters more, and even that is poorly characterized for panic specifically [11]. Disputed
- Terpene folklore (e.g., linalool or myrcene calming panic) — interesting preclinical signals, but no clinical trials in panic disorder. No data
- Daily heavy cannabis use to prevent panic attacks. Observational data link heavy use to higher rates of anxiety disorders and panic symptoms over time [5][12]. Tolerance and withdrawal-induced anxiety are also real. [evidence:weak-to-moderate for harm]
What we don't know
- Whether pharmaceutical-grade CBD reduces frequency of panic attacks in diagnosed panic disorder.
- Optimal CBD dose, duration, and product type (the 2011 study used 600 mg, far higher than typical retail dosing) [6].
- Whether very-low-dose THC plus CBD has any role, or whether THC's panic-inducing effects dominate.
- Long-term outcomes: does cannabis use change the natural course of panic disorder, including agoraphobia?
- Interactions with SSRIs, benzodiazepines, and CBT-based exposure work — including whether cannabis use blunts the learning that makes exposure therapy work [13]. Weak / limited
Comparison with standard treatments
| Treatment | Evidence in panic disorder | Typical role | |---|---|---| | CBT (with exposure) | Strong [8][9] | First-line | | SSRIs / SNRIs | Strong [8] | First-line | | Benzodiazepines | Strong short-term [8] | Rescue / short-term | | CBD (isolate or broad-spectrum) | None directly; weak indirect [6][7][10] | Not established | | THC-dominant cannabis | None for benefit; documented acute harm [2][3] | Not recommended as treatment |
If cost or access is the barrier to standard care, internet-delivered CBT programs and generic SSRIs are often dramatically cheaper than cannabis products and have actual evidence behind them.
Risks specific to panic disorder
- Acute panic attacks triggered by THC are common enough that emergency departments see them regularly, particularly with edibles where dose timing is unpredictable [2][3].
- Sensitization. People with panic disorder are, by definition, hyper-attentive to bodily sensations. THC produces tachycardia, derealization, and dizziness — exactly the sensations panic patients catastrophize. This can fuel future attacks.
- Cannabis use disorder. Risk of dependence is roughly 10% of users overall, higher with daily use and early initiation [14].
- Withdrawal anxiety. Cessation after regular use can produce anxiety, irritability, and sleep disturbance that mimics or worsens panic [15].
- Avoidance. Using cannabis to prevent panic attacks can become a safety behavior that blocks the exposure-based learning that CBT relies on [13].
If you currently use cannabis and have panic disorder, do not stop abruptly without talking to a clinician, especially if you are on other psychiatric medications. Taper, switch to lower-THC products, or seek support.
Sources
- Book American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Publishing.
- Peer-reviewed Crippa, J. A., Zuardi, A. W., Martín-Santos, R., et al. (2009). Cannabis and anxiety: a critical review of the evidence. Human Psychopharmacology: Clinical and Experimental, 24(7), 515-523.
- Peer-reviewed Hall, W., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. The Lancet, 374(9698), 1383-1391.
- Peer-reviewed Bonn-Miller, M. O., Vujanovic, A. A., Feldner, M. T., et al. (2007). Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. Journal of Traumatic Stress, 20(4), 577-586.
- Peer-reviewed Kedzior, K. K., & Laeber, L. T. (2014). A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population — a meta-analysis of 31 studies. BMC Psychiatry, 14, 136.
- Peer-reviewed Bergamaschi, M. M., Queiroz, R. H., Chagas, M. H., et al. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology, 36(6), 1219-1226.
- Peer-reviewed Shannon, S., Lewis, N., Lee, H., & Hughes, S. (2019). Cannabidiol in anxiety and sleep: a large case series. The Permanente Journal, 23, 18-041.
- Government National Institute for Health and Care Excellence (NICE). (2011, updated). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline [CG113]. ↗
- Peer-reviewed Pompoli, A., Furukawa, T. A., Imai, H., et al. (2016). Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database of Systematic Reviews, (4), CD011004.
- Peer-reviewed Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44-46.
- Peer-reviewed Zvolensky, M. J., Bernstein, A., Sachs-Ericsson, N., et al. (2006). Lifetime associations between cannabis use, abuse, and dependence and panic attacks in a representative sample. Journal of Psychiatric Research, 40(6), 477-486.
- Peer-reviewed Papini, S., Sullivan, G. M., Hien, D. A., et al. (2015). Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder. Current Psychiatry Reports, 17(6), 41.
- Peer-reviewed Hasin, D. S., Saha, T. D., Kerridge, B. T., et al. (2015). Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242.
- Peer-reviewed Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161(11), 1967-1977.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Cannabis and Generalized Anxiety Disorder — What the evidence actually says about using cannabis, CBD, and THC for chronic, persistent...
- Cannabis Use Disorder — A real DSM-5 diagnosis affecting roughly 1 in 5 regular users, with modest but growing evi...